| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.33 | 1e-07 |
| mRNA | BMS-345541 | GDSC1000 | pan-cancer | AAC | 0.2 | 3e-07 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.18 | 1e-06 |
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | 0.2 | 1e-06 |
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | 0.18 | 2e-06 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | 0.19 | 4e-06 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | 0.22 | 5e-06 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | 0.18 | 9e-06 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | 0.2 | 1e-05 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.18 | 1e-05 |